Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
11/09/2023 21:32
Sept 11 (Reuters) - Infinity Pharmaceuticals Inc
INFI.O :
* INFINITY PHARMA-ON SEPT 5, 2023, CO RECEIVED LETTER FROM
NASDAQ
NOTIFYING THAT LISTING OF COMMON STOCK WAS NOT IN COMPLIANCE
WITH NASDAQ LISTING RULE
Further company coverage: INFI.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX